ArticleCancer immunology, immunotherapy : CII2025

Exploring IgSF11 as a potential immune checkpoint and immunotherapeutic target in breast cancer.

Ibtissam Rezouki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.